To include your compound in the COVID-19 Resource Center, submit it here.

CRISPR stocks add over $530 million in market cap

Another multi-billion dollar biotech takeout and the publication of two papers in Nature journals conspired to lift CRISPR-based stocks on a busy Monday.

CRISPR

Read the full 237 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE